Method of quenching electronic excitation of chromophore-containing organic molecules in photoactive compositions

Information

  • Patent Grant
  • 7713519
  • Patent Number
    7,713,519
  • Date Filed
    Wednesday, October 29, 2008
    16 years ago
  • Date Issued
    Tuesday, May 11, 2010
    14 years ago
Abstract
The photostabilizing electronic excited state energy—particularly singlet state energy from a UV-absorbing molecule has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds of formulas (I) and (V) having an alkoxy radical preferably in the four (para) position (hereinafter methoxy crylenes) on one or both of the phenyl rings:
Description
FIELD OF THE INVENTION

The present invention is directed to a method of quenching electronic excited state(s) of chromophore-containing UV-absorbing organic molecules in photoactive compositions. More particularly, it has been found that α-cyano-β,β diphenylacrylates (crylenes) having an alkoxy radical, preferably on one of the phenyl rings (alternatively on both phenyl rings), quenches the excited state of the chromophore by accepting the excited state energy (singlet and sometimes also the triplet state), thereby returning the UV-absorbing molecule back to its ground state so that the chromophore can absorb more photons, e.g., from ultraviolet (UV) light, thereby photostabilizing UV-absorbing chromophore-containing organic molecules, particularly butyl methoxydibenzoylmethane (Avobenzone), octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate) in photoactive compositions.


BACKGROUND

The absorption of ultraviolet light by a chromophore-containing organic molecule causes the excitation of an electron in the chromophore moiety from an initially occupied, low energy orbital to a higher energy, previously unoccupied orbital. The energy of the absorbed photon is used to energize an electron and cause it to “jump” to a higher energy orbital, see Turro, Modern Molecular Photochemistry, 1991. Two excited electronic states derive from the electronic orbital configuration produced by UV light absorption. In one state, the electron spins are paired (antiparallel) and in the other state the electron spins are unpaired (parallel). The state with paired spins has no resultant spin magnetic moment, but the state with unpaired spins possesses a net spin magnetic moment. A state with paired spins remains a single state in the presence of a magnetic field, and is termed a singlet state. A state with unpaired spins interacts with a magnetic field and splits into three quantized states, and is termed a triplet state.


In the electronically excited state, the chromophore-containing organic molecule is prone to degrade via a number of known pathways and, therefore, can absorb little or no additional UV light. To photostabilize an electronically excited chromophore-containing organic molecule in order to provide sufficient UV protection, it must be returned to the ground state before it undergoes a photochemical reaction destructive to its UV absorbing capability. There are known photostabilizing sunscreen additives, such as Octocrylene, methylbenzilydene camphor, and the esters or polyesters of naphthalene dicarboxylic acid of this assignee's U.S. Pat. Nos. 6,113,931; 6,284,916; 6,518,451; and 6,551,605, all hereby incorporated by reference, that are capable of quenching excited triplet state energy. Surprisingly, it has been found that alkoxy crylenes, particularly methoxy crylenes, return chromophore-containing organic molecules, particularly butyl methoxydibenzoylmethane (Avobenzone), octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate), from both an electronically excited singlet state and excited triplet state back to their ground state, thereby photostabilizing the UV-absorbing organic molecules.


Deflandre U.S. Pat. No. 5,576,354 generally discloses a cosmetic sunscreen composition containing at least 1% by weight of an α-cyano-β,β-diphenylacrylate that will photostabilize a dibenzoylmethane derivative, e.g., Parsol 1789 (Avobenzone), so long as the composition contains a fatty phase, e.g., glycerol stearates, isopropyl myristate or the like, and so long as the mole ratio of the α-cyano-β,β-diphenylacrylate to the dibenzoylmethane derivative is at least 0.8. The compounds preferred in the '354 patent and disclosed in the examples are octocrylene, which contains no alkoxy radical(s) (UVINULN 539); β,β-bis(4-methoxyphenyl)acrylates (containing no cyano radical); and the α-cyano-β,β-diphenylacrylates, which contain no alkoxy radical(s).


As stated in this assignees pending application Ser. Nos. 10/241,388; 10/361,223; and 10/786,793, an α-cyano-β,β-diphenylacrylate compound (e.g., octocrylene) is known to quench (accept) the excited triplet state energy of an excited photoactive compound by dissipating the energy kinetically in the form of rapid isomerizations. This process is shown below:




embedded image



wherein the α-cyano-β,β-diphenylacrylate compound (octocrylene shown above as structure A), accepts the triplet excited state energy from a photoactive compound and forms a diradical (shown above as structure A*) at the α and β positions of the acrylate, which converts the double bond into a single bond and allows for the free rotation of the phenyl groups. This rotation occurs rapidly and efficiently to dissipate any excited triplet state energy accepted by the α-cyano-β,β-diphenylacrylate compound from the photoactive compound.


While octocrylene is able to quench (accept) the triplet excited state energy from a photoactive compound, thereby photostabilizing, to some degree, dibenzoylmethane derivatives, as shown in examples 1, 4, 6 and 8 of Deflandre et al. U.S. Pat. No. 5,576,354, hereby incorporated by reference, there exists a need in the photoactive composition art to find one or more compounds that quench (accept) the singlet excited state energy and preferably also the triplet excited state energy from photoactive compounds, which octocrylene does not.


Quite surprisingly, it has been found that the alkoxy substituted α-cyano-β,β-diphenylacrylates (alkoxy crylenes) will quench the electronically excited singlet state energy of UV-absorbing organic molecules, such as the dibenzoylmethane derivatives of U.S. Pat. No. 5,576,354, even at very low loadings compared to the quantity of UV-absorbing compounds.


SUMMARY

The photostabilizing electronic excited state energy—particularly singlet state energy from a UV-absorbing molecule—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinafter methoxy crylenes) on one or both of the phenyl rings having the formula (I):




embedded image



wherein one or both of R1 and R2 is a straight or branched chain C1-C30 alkoxy radical, preferably C1-C8, more preferably methoxy, and any non-alkoxy radical R1 or R2 is hydrogen; and R3 is a straight or branched chain C1-C30 alkyl radical, preferably C2-C20.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a graph showing the photostability of the sunscreen compositions of Examples 1-3 (when irradiated with 35 MED of UV radiation) provided by 4.5% octyldocedyl methoxy crylene (C2OMC); and 2.75% Octocrylene (OC) compared to the photostability prior to UV irradiation and compared to the composition with no photo stabilizer;



FIG. 2 is a graph showing to photostability of the sunscreen composition of Example 4 before and after irradiation with 35 MED of UV radiation;



FIG. 3 is a graph showing to photostability of the sunscreen composition of Example 5 before and after irradiation with 35 MED of UV radiation; and



FIG. 4 is a graph showing to photostability of the sunscreen composition of Example 6 before and after irradiation with 35 MED of UV radiation;





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment.


The term “alkoxy” herein refers to a radical extending from the para position of one or both of the phenyl rings having the formula O—R, wherein R is an alkyl radical, straight chain or branched having 1 to 30 carbon atoms, preferably wherein R═C1 to C8, more preferably C2-C20, and most preferably —O—CH3 (methoxy). The oxygen atom of the alkoxy radical is covalently bonded to the para carbon atom of one or both of the phenyl rings, preferably only one of the phenyls, preferably having the formula (II) or (III):




embedded image



wherein R3 is as previously defined.


The term “crylene” as used herein refers to a chromophoric moiety that includes an α-cyano-β,β-diphenyl propanoic acid ester.


The term “cyano” as used herein refers to a —C≡N group, also designated “—CN.”


Photoactive compositions, e.g., sunscreen compositions, generally include UV-A and UV-B photoactive compounds in a cosmetically acceptable carrier, optionally including additives, such as emollients, stabilizers, emulsifiers, and combinations thereof. These additives can be used in preparing a UV filter composition in an emulsion (oil-in-water or water-in-oil) from a composition that includes one or more photoactive compounds and a solvent or a solvent combination that includes one or more organic solvents and water. When made, preferably the emulsion is an oil-in-water emulsion, wherein the oil phase is primarily formed from a mixture of the UV filter compound(s) and one or more organic solvents.


A typical photoactive composition includes one or more photoactive compounds, wherein the photoactive compound(s) act to absorb UV radiation and thereby protect the substrate (e.g., human skin, resins, films, and the like) from the harmful effects of UV radiation. The absorption process causes a photoactive compound to reach an excited state, wherein the excited state is characterized by the presence of excited electronic energy (e.g., singlet state energy or triplet state energy), as compared to the ground state of the photoactive compound. Once a photoactive compound reaches an excited state there exists a number of pathways by which the excited photoactive compound can dissipate its excess energy (e.g., singlet and/or triplet energy), however, many of those pathways adversely affect the ability of the photoactive compound to further absorb UV radiation. The alkoxy crylene molecules described herein accept electronic singlet excited state energy from UV-absorbers, particularly Avobenzone, octyl methoxycinnamate (Octinoxate), and octyl salicylate (Octisalate). The alkoxy crylenes also are very effective UVA absorbers in addition to providing electronic singlet state energy quenching of other UV-absorbing compounds in sunscreen compositions. The alkoxy crylene molecules described herein are especially effective when combined with one or more additional electronic singlet excited state quenching compounds such as oxybenzone. Particularly surprising photostabilization is achieved in sunscreen compositions containing the alkoxy crylene molecules described herein together with octyl methoxycinnamate and Avobenzone. The molar ratio of a compound of formula (I) to the photoactive compound can be less than 0.8, particularly about 0.1 to about 0.6.


A photoactive compound is one that responds to light photoelectrically. In the compositions and methods of photostabilization disclosed herein, a photoactive compound is one that responds to UV radiation photoelectrically. For example, all photoactive compound-containing compositions that respond to UV radiation photoelectrically by photoactive compound photodegradation benefit highly by the inclusion of the alkoxy crylene molecules described herein. The alkoxy crylenes described herein are useful photostabilizers and/or photoactive compounds when combined with any single or combination photoactive compounds identified in Shaath, Nadim, Encyclopedia of UV filters, ©2007, hereby incorporated by reference. Photostability is a problem with all UV filters because they all reach an electronic singlet excited state upon exposure to UV radiation.


It is theorized that the following UV filters are photostabilized by the alkoxy crylene molecules described herein, including all of the following, including combinations of any two or more, and include compounds selected from the following categories (with specific examples) including: p-aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid); anthranilates (o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl (homosalate), glyceryl, and dipropyleneglycol esters); cinnamic acid derivatives (menthyl and benzyl esters, alpha-phenyl cinnamonitrile; butyl cinnamoyl pyruvate); dihydroxycinnamic acid derivatives (umbelliferone, methylumbelliferone, methylaceto-umbelliferone); camphor derivatives (3 benzylidene, 4 methylbenzylidene, polyacrylamidomethyl benzylidene, benzalkonium methosulfate, benzylidene camphor sulfonic acid, and terephthalylidene dicamphor sulfonic acid); trihydroxycinnamic acid derivatives (esculetin, methylesculetin, daphnetin, and the glucosides, esculin and daphnin); hydrocarbons (diphenylbutadiene, stilbene); dibenzalacetone; benzalacetophenone; naphtholsulfonates (sodium salts of 2-naphthol-3,6-disulfonic and of 2-naphthol-6,8-disulfonic acids); dihydroxy-naphthoic acid and its salts; o- and p-hydroxydiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyl, 3-phenyl); diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl naphthoxazole, various aryl benzothiazoles); quinine salts (bisulfate, sulfate, chloride, oleate, and tannate); quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline); hydroxy- or methoxy-substituted benzophenones; uric acid derivatives; vilouric acid derivatives; tannic acid and its derivatives; hydroquinone; and benzophenones (oxybenzone, sulisobenzone, dioxybenzone, benzoresorcinol, octabenzone, 4-isopropyldibenzoylmethane, butylmethoxydibenzoylmethane, etocrylene, and 4-isopropyl-dibenzoylmethane).


The following UV filters should be particularly photostabilized by the alkoxy crylene molecules described herein: 2-ethylhexyl p-methoxycinnamate, 4,4′-t-butyl methoxydibenzoylmethane, octyldimethyl p-aminobenzoate, digalloyltrioleate, ethyl 4-[bis(hydroxypropyl)]aminobenzoate, 2-ethylhexylsalicylate, glycerol p-aminobenzoate, 3,3,5-trimethylcyclohexylsalicylate, and combinations thereof.


Photoactive compositions disclosed herein can include a variety of photoactive compounds, preferably including one or more UV-A photoactive compounds and one or more UV-B photoactive compounds. Preferably, a sunscreen composition includes a photoactive compound selected from the group consisting of p-aminobenzoic acid and salts and derivatives thereof; anthranilate and derivatives thereof; dibenzoylmethane and derivatives thereof; salicylate and derivatives thereof; cinnamic acid and derivatives thereof; dihydroxycinnamic acid and derivatives thereof; camphor and salts and derivatives thereof; trihydroxycinnamic acid and derivatives thereof; dibenzalacetone naphtholsulfonate and salts and derivatives thereof; benzalacetophenone naphtholsulfonate and salts and derivatives thereof; dihydroxy-naphthoic acid and salts thereof; o-hydroxydiphenyldisulfonate and salts and derivatives thereof; p-hydroxydiphenyldisulfonate and salts and derivatives thereof; coumarin and derivatives thereof; diazole derivatives; quinine derivatives and salts thereof; quinoline derivatives; uric acid derivatives; vilouric acid derivatives; tannic acid and derivatives thereof; hydroquinone; diethylamino hydroxybenzoyl hexyl benzoate and salts and derivatives thereof; and combinations of the foregoing.


UV A radiation (about 320 nm to about 400 nm), is recognized as contributing to causing damage to skin, particularly to very lightly colored or sensitive skin. A sunscreen composition disclosed herein preferably includes a UV-A photoactive compound. Preferably, a sunscreen composition disclosed herein includes a dibenzoylmethane derivative UV-A photoactive compound. Preferred dibenzoylmethane derivatives include, 2-methyldibenzoylmethane; 4-methyldibenzoylmethane; 4-isopropyldibenzoylmethane; 4-tert-butyldibenzoylmethane; 2,4-dimethyldibenzoylmethane; 2,5-dimethyldibenzoylmethane; 4,4′-diisopropyldibenzoylmethane; 4,4′-dimethoxydibenzoylmethane; 4-tert-butyl-4′-methoxydibenzoylmethane; 2-methyl-5-isopropyl-4′-methoxydibenzoylmethane; 2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane; 2,4-dimethyl-4′-methoxydibenzoylmethane; 2,6-dimethyl-4-tert-butyl-4′-methoxydibenzoylmethane, and combinations thereof.


For a product marketed in the United States, preferred cosmetically acceptable photoactive compounds and concentrations (reported as a percentage by weight of the total cosmetic sunscreen composition) include: aminobenzoic acid (also called para aminobenzoic acid and PABA; 15% or less), Avobenzone (also called butyl methoxy dibenzoylmethane; 3% or less), cinoxate (also called 2 ethoxyethyl p methoxycinnamate; 3% or less), dioxybenzone (also called benzophenone 8; 3% or less), homosalate ((also called 3,3,5-trimethylcyclohexyl salicylate, 15% or less), menthyl anthranilate (also called menthyl 2 aminobenzoate; 5% or less), octocrylene (also called 2 ethylhexyl 2 cyano 3,3 diphenylacrylate; 10% or less), octyl methoxycinnamate (7.5% or less), octyl salicylate (also called 2 ethylhexyl salicylate; 5% or less), oxybenzone (also called benzophenone 3; 6% or less), padimate O (also called octyl dimethyl PABA; 8% or less), phenylbenzimidazole sulfonic acid (water soluble; 4% or less), sulisobenzone (also called benzophenone 4; 10% or less), titanium dioxide (25% or less), trolamine salicylate (also called triethanolamine salicylate; 12% or less), and zinc oxide (25% or less).


Other preferred cosmetically acceptable photoactive compounds and preferred concentrations (percent by weight of the total cosmetic sunscreen composition) include diethanolamine methoxycinnamate (10% or less), ethyl-[bis(hydroxypropyl)]aminobenzoate (5% or less), glyceryl aminobenzoate (3% or less), 4 isopropyl dibenzoylmethane (5% or less), 4 methylbenzylidene camphor (6% or less), terephthalylidene dicamphor sulfonic acid (10% or less), and sulisobenzone (also called benzophenone 4, 10% or less).


For a product marketed in the European Union, preferred cosmetically acceptable photoactive compounds and preferred concentrations (reported as a percentage by weight of the total cosmetic sunscreen composition) include: PABA (5% or less), camphor benzalkonium methosulfate (6% or less), homosalate (10% or less), benzophenone 3 (10% or less), phenylbenzimidazole sulfonic acid (8% or less, expressed as acid), terephthalidene dicamphor sulfonic acid (10% or less, expressed as acid), butyl methoxydibenzoylmethane (5% or less), benzylidene camphor sulfonic acid (6% or less, expressed as acid), octocrylene (10% or less, expressed as acid), polyacrylamidomethyl benzylidene camphor (6% or less), ethylhexyl methoxycinnamate (10% or less), PEG 25 PABA (10% or less), isoamyl p methoxycinnamate (10% or less), ethylhexyl triazone (5% or less), drometrizole trielloxane (15% or less), diethylhexyl butamido triazone (10% or less), 4 methylbenzylidene camphor (4% or less), 3 benzylidene camphor (2% or less), ethylhexyl salicylate (5% or less), ethylhexyl dimethyl PABA (8% or less), benzophenone 4 (5%, expressed as acid), methylene bis benztriazolyl tetramethylbutylphenol (10% or less), disodium phenyl dibenzimidazole tetrasulfonate (10% or less, expressed as acid), bis ethylhexyloxyphenol methoxyphenol triazine (10% or less), methylene bisbenzotriazolyl tetramethylbutylphenol (10% or less, also called TINOSORB M or Bisoctrizole), and bisethylhexyloxyphenol methoxyphenyl triazine. (10% or less, also called TINOSORB S or Bemotrizinol).


All of the above described UV filters are commercially available. For example, suitable commercially available organic UV filters are identified by trade name and supplier in Table I below:











TABLE I





CTFA Name
Trade Name
Supplier







benzophenone-3
UVINUL M-40
BASF Chemical Co.


benzophenone-4
UVINUL MS-40
BASF Chemical Co.


benzophenone-8
SPECTRA-SORB
American Cyanamid



UV-24


DEA-methoxycinnamate
BERNEL HYDRO
Bernel Chemical


diethylamino
UVINUL A-PLUS
BASF Chemical Co.


hydroxybenzoyl hexyl


benzoate


diethylhexyl butamido
UVISORB HEB
3V-Sigma


triazone


disodium phenyl
NEO HELIOPAN AP
Symrise


dibenzylimidazole


ethyl dihydroxypropyl-
AMERSCREEN P
Amerchol Corp.


PABA


glyceryl PABA
NIPA G.M.P.A.
Nipa Labs.


homosalate
KEMESTER HMS
Humko Chemical


menthyl anthranilate
SUNAROME UVA
Felton Worldwide


octocrylene
UVINUL N-539
BASF Chemical Co.


octyl dimethyl PABA
AMERSCOL
Amerchol Corp.


octyl methoxycinnamate
PARSOL MCX
Bernel Chemical


PABA
PABA
National Starch


2-phenylbenzimidazole-
EUSOLEX 6300
EM Industries


5-sulphonic acid


TEA salicylate
SUNAROME W
Felton Worldwide


2-(4-methylbenzildene)-
EUSOLEX 6300
EM Industries


camphor


benzophenone-1
UVINUL 400
BASF Chemical Co.


benzophenone-2
UVINUL D-50
BASF Chemical Co.


benzophenone-6
UVINUL D-49
BASF Chemical Co.


benzophenone-12
UVINUL 408
BASF Chemical Co.


4-isopropyl dibenzoyl
EUSOLEX 8020
EM Industries


methane


butyl methoxy dibenzoyl
PARSOL 1789
Givaudan Corp.


methane


etocrylene
UVINUL N-35
BASF Chemical Co.


methylene bisbenzotriazolyl
TINOSORB M
Ciba Specialty


tetramethylbutylphenol

Chemicals


bisethylhexyloxyphenol
TINOSORB S
Ciba Specialty


methoxyphenyl triazine.

Chemicals









Commonly-assigned U.S. Pat. Nos. 6,485,713 and 6,537,529, the disclosures of which are hereby incorporated herein by reference, describe compositions and methods for increasing the photostability of photoactive compounds in a sunscreen composition, e.g., by the addition of polar solvents to the oil phase of a composition. By increasing the polarity of the oil phase of a sunscreen composition including the alkoxy crylenes described herein, e.g., methoxy crylene, the stability of the sunscreen composition is surprisingly increased in comparison to octocrylene. In the sunscreen compositions described herein, preferably, one or more of a highly polar solvent is present in the oil-phase of the composition. Preferably, a sufficient amount of a polar solvent is present in the sunscreen composition to raise the dielectric constant of the oil-phase of the composition to a dielectric constant of at least about 7, preferably at least about 8. With or without the highly polar solvent in the oil phase, the methoxy crylene molecules described herein yield unexpected photostability in comparison to octocrylene.


A photoactive compound can be considered stable when, for example, after 30 MED irradiation the photoactive compound has retained at least about 90% of its original absorbance at a wavelength, or over a range of wavelengths of interest (e.g., the wavelength at which a photoactive compound has a peak absorbance, such as 350-370 nm for Avobenzone). Likewise, a sunscreen composition can include a plurality of photoactive compounds and a sunscreen composition, as a whole, can be considered stable when, for example, after 30 MED irradiation the sunscreen composition has retained at least about 90% of its original absorbance at one or more wavelengths of interest (e.g., at or near the peak absorbance wavelength of the primary photoactive compound).


Synthesis of methyl or ethyl 2-cyano-3-(4′-methoxyphenyl)-3-phenylpropenoate (Methyl or Ethyl Methoxycrylene or Methyl or Ethyl MeOcrylene)



embedded image



4-Methoxy benzophenone (MW=182.22 g/mole; 500 g; 2.74 mole; 1 mole equivalence) and methyl cyanoacetate (MW=99.09 g/mole; 367.06 g; 3.70 mole; 1.35 mole equivalence) were placed in 1-L 3-neck flask assembled with mechanical stirrer and nitrogen inlet, which provided continuous flow of nitrogen through the reaction mixture (nitrogen is bubbled through the reaction mixture). Next, toluene (1200 ml) and acetic acid (240 ml; ratio of toluene/acetic acid=5/1) are added to the flask followed by ammonium acetate (MW=77.09 g/mole; 21.12 g; 0.274 mole, 0.1 mole equivalence; the catalyst is added 4 times this amount during reaction time). The flask is then assembled with Dean-Stark receiver through which reaction water is being continuously removed.


Comments:

    • 1. Aliquots of the reaction mixture are taken to check the rate of completion of the reaction.
    • 2. The amount of water expected from this reaction is 49.5 ml. However, I collected about 120 ml of water phase. This is due to the fact that the water is distilled in form of a mixture, water/acetic acid/toluene.
    • 3. To prevent from loosing the methyl acetate from the reaction mixture, it helps to put a short packed column between Dean-Stark receiver and the flask.


Work-up:


The reaction mixture is cooled to room temperature and ethyl acetate is added to dissolve all solids before the crude mixture is washed several time with water, to remove acetic acid and salts. The solvents are then removed from the reaction mixture by distillation. The crude solid product is re-crystallized from hot methanol (or toluene/methanol mixture, if such is preferred).


Comments:


The finished product begins to crystallize out from the cooling reaction mixture and thus can be filtered off, but it still is very acidic, so the crystals ought to be washed with water/methanol mixture to wash out any acetic acid and salts residues. Thus obtained the product then can be re-crystallized and the mother liquor can be washed with water, dried, and second crop of the product can be obtained.


Synthesis of Alkyl 2-cyano-3-(4′-methoxyphenyl)-3-phenylpropenoate:




embedded image


Reaction Procedure:


Methyl (or ethyl) 2-cyano-3-(4′-methoxyphenyl)-3-phenylpropenoate (900 g, 3.06 mole; MW=293.32), alkyl alcohol (3.84 mole; 1.25 mole equivalence), and Tegokat 250 (0.03% of total batch weight) were placed in 2 L 3-neck round-bottom flask and heated to temperature set at 185 C (365 F), with nitrogen purging it well to remove forming methanol (or ethanol) via the simple distillation setup with packed column.


After 3 h, GC showed full conversion of methyl 2-cyano-3-(4′-methoxyphenyl)-3-phenylpropenoate to the desired product.


Work-up:


The unreacted alkyl alcohol was completely removed by vacuum distillation. Temperature of the reaction was lowered to 110 C (230 F) and calculated amount (2% of total batch weight) of the SSP (tin removing agent) was added. The product was stirred at this temperature for 2 hours and then filtered hot. Small amount of celite was added right before filtration to enhance the filtration—with celite the filtration was more efficient and faster.


Results:


Yield of the product - - - 94% of stoichiometric amount


Purity of finished product - - - 99.81% (area count, GC).


EXAMPLES

The following compositions (Table I) were prepared according to the procedure indicated in order to show the photostability effect of the alkoxy crylenes described herein. The compound described as “methoxy crylene” had the following formula (IV):




embedded image












COMPOSITIONS OF FORMULATIONS TESTED FOR


PHOTOSTABILITY













Example 1
Example 2
Example 3




(4.5% C20
(POS:
(NEG: No




Methoxy-
2.75%
Photo-


#
Ingredients
crylene)
OC Only)
stabilizer)















Oil Phase Ingredients





1
Avobenzone
3.00%
3.00%
3.00%


2
Octisalate
5.00%
5.00%
5.00%


3
Homosalate
7.50%
7.50%
7.50%


4
Benzophenone-3
0.49%
0.49%
0.49%


5
Octocrylene*** (OC)
0.00%
2.75%
0.00%


6
C20 Methoxycrylene***
4.50%
0.00%
0.00%



(C20MC)


7
Phenylethyl benzoate
0.00%
0.00%
2.75%


8
Dimethicone (350 cSt)
1.25%
1.25%
1.25%


9
Methyl trimethicone
0.00%
1.75%
1.75%


10
VP/Eicosene copolymer
1.00%
1.00%
1.00%


11
Cetearyl alcohol
0.36%
0.36%
0.36%



Total Oil Ingredients
23.10%
23.10%
23.10%



Emulsifiers


12
Steareth-21
0.80%
0.80%
0.80%


13
Steareth-2
0.60%
0.60%
0.60%


14
Potassium cetyl phosphate &
3.00%
3.00%
3.00%



Hydrogenated palm glycerides




Total Emulsifiers
4.40%
4.40%
4.40%



Water Phase Ingredients


15
Disodium EDTA
0.10%
0.10%
0.10%


16
Glycerin
4.00%
4.00%
4.00%


17
Benzyl alcohol
1.00%
1.00%
1.00%


18
Methylparaben
0.10%
0.10%
0.10%


19
Propylparaben
0.05%
0.05%
0.05%


20
Water
62.25%
62.25%
62.25%



Total Water Ingredients
67.50%
67.50%
67.50%



Other Ingredients


21
Acrylamide/Sodium acryloyl-
2.50%
2.50%
2.50%



dimethyl taurate copolymer


22
Aluminum starch octenyl
2.50%
2.50%
2.50%



succinate




Total Other Ingredients
5.00%
5.00%
5.00%



Total
100.00%
100.00%
100.00%





**Reported as Coefficients of Variation on report generated by Labsphere instrument


***On a molar basis, 4.5% C20 methoxycrylene is equal to 2.75% Octocrylene


PROCEDURE


1. Charge secondary vessel with 1-7. With stirring, heat to 90° C. Add in order 10-14. Continue stirring until homogeneous.


2. Charged primary vessel with water (20). With stirring, ad 15-16. Heat to 90° C.


3. Add oil phase (1-7, 10-14) to water phase (20, 15, 16). Stir vigorously for 10 minutes. Switch to homomixer and homogenize until temperature


4. When temperature of emulsion is below 55° C., switch to sweep stirring. Preblend 17-19. Add to emulsion when temperature is below 45° C.


5. Add 21 and continue sweep stirring as emulsion thickens. When smooth, add 22. Pre-blend 8 and 9 and add to batch.


6. Q.S. water and package when temperature of batch is less than 35° C.


*ST-006-033






The surprising photostability of the sunscreen compositions of Table I, including methoxy crylene, in comparison to the octocrylene of the prior art, is shown in FIG. 1, which is a graph of the data of Examples 1 through 3, above, and in the following SPF reports for Examples 4-6.












TABLE 2








Example 4
Example 5
Example 6



(7%
(0%



Ethylhexyl
Ethylhexyl
(8.8%



methoxy-
methoxy-
Octo-


Results at Irradiation with 35 MED
crylene)
crylene)
crylene)





Loss of UVA protection**
−18.26%
−80.47%
−55.96%


Loss of UVB protection**
−6.46%
−52.01%
−4.51%


Loss of SPF**
−7.43%
−70.42%
−16.00%










**Reported as Coefficients of Variation on report generated by Labsphere


instrument software.







COMPOSITIONS OF FORMULATIONS TESTED FOR


PHOTOSTABILITY













CAB6-057
CAB6-058
CAB6-060




(7%
(0%
(0%




Ethylhexyl
Ethylhexyl
Ethylhexyl




methoxy-
methoxy-
methoxy-


#
Ingredients
crylene)
crylene)
crylene)






Oil Phase Ingredients


 1
Avobenzone
2.00%
2.00%
2.00%


 2
Octyl memthoxycinnamate
5.00%
5.00%
5.00%



(OMC)


 3
Phenylethyl benzoate
7.50%
7.50%
7.50%


 4
Benzophenone-3
0.49%
0.49%
0.49%


 5
Octocrylene
1.80%
1.80%
8.80%


 6
Ethylhexyl methoxycrylene***
7.00%
0.00%
0.00%


 7
Polyisobutene
0.00%
7.00%
0.00%



Total Oil Ingredients
23.79%
23.79%
23.79%



Emulsifier


 8
Acrylates/C10-30 alkyl acrylate
0.25%
0.25%
0.25%



crosspolymer


 9
Sorbitan laurate
0.20%
0.20%
0.20%



Total Emulsifiers
0.45%
0.45%
0.45%


x
Water Phase Ingredients


10
Disodium EDTA
0.10%
0.10%
0.10%


11
Cetyl hydroxyethylcellulose
0.30%
0.30%
0.30%


12
Glycerin
4.00%
4.00%
4.00%


13
Benzyl alcohol
1.00%
1.00%
1.00%


14
Methylparaben
0.10%
0.10%
0.10%


15
Propylparaben
0.05%
0.05%
0.05%


16
Triethanolamine
0.40%
0.40%
0.40%


17
Water
69.81%
69.81%
69.81%



Total Water Ingredients
75.76%
75.76%
75.76%



Total
100.00%
100.00%
100.00%





PROCEDURE


1. Change primary vessel with water (16). Dissolve 10. Heatto 85 degrees C. Dispense 11. Remove from heat. Continue stirring until 11 is fully dissolved.


2. In secondary vessel, add 2-7 and 9 with stirring. Add 1 and heat to 45 degrees C. Continue stirring until solution is clear.


3. Add 8 to oil and stir until completely incorporated.


4. When oil phase and water phase are 45 degrees C., add oil (1-7, 8, 9) to water (17, 10, 11). Maintain temperature and stir for 30 minutes.


5. Remove batch from heat. Preblend 12 and 16. Add to batch with stirring. Increase agitation as batch thickens.


6. Preblend 13-15, making sure that 14 and 15 are completely dissolved. Add to batch. Q.S. water and package when temperature of batch is less than 35° C.






Additional methoxy crylene molecules were tested in accordance with the procedure indicated in Table 2, wherein radical R3 of the methoxy crylene of formula (I) has an R3=ethyl hexyl (formula V):




embedded image



The data for the sunscreen composition of Example 4 is shown in the graph of FIG. 2 and the data for the composition of Example 5 is shown in the graph of FIG. 3. For Examples 4-6, the data of Example 6 (shown in graph form as FIG. 4) compares 7% ethylhexyl methoxy crylene (formula V) and 1.8% octocrylene (Example 4) to 8.8% octocrylene with no alkoxy crylene. As shown in the graph of FIG. 4 and the following SPF reports for Examples 4-6, the alkoxy crylenes described herein are unexpectedly better photostabilizers than octocrylene.












SPF REPORT


















Sample:
Example 4 UV Photostability



Comment:
0, 35 MED



Wavelength Range:
290-400 nm










Units:















SPF
T(UVA)
T(UVB)




# of Scans:
2
2
2



Mean:
24.67
4.52%
5.43%



STD:
1.83
0.83%
0.35%



COV:
7.43%
18.26%
6.46%



UVA/UVB Ratio:
1.1










Boots Star Rating:
N/A less than 5 Scans












Scan #
SPF
Critical Wavelength




1
25.97
385



2
23.37
384




















SPF REPORT


















Sample:
Example 5 UV Photostability



Comment:
0, 35 MED



Wavelength Range:
290-400 nm










Units:















SPF
T(UVA)
T(UVB)




# of Scans:
2
2
2



Mean:
16.76
23.10%
8.07%



STD:
11.8
18.59%
4.20%



COV:
70.42%
80.47%
52.01%



UVA/UVB Ratio:
0.72










Boots Star Rating:
N/A less than 5 Scans












Scan #
SPF
Critical Wavelength




1
25.11
380



2
 8.41
372




















SPF REPORT


















Sample:
Example 6 UV Photostability



Comment:
0, 35 MED



Wavelength Range:
290-400 nm










Units:















SPF
T(UVA)
T(UVB)




# of Scans:
2
2
2



Mean:
23.83
11.80%
5.27%



STD:
3.81
6.61%
0.24%



COV:
16.00%
55.96%
4.51%



UVA/UVB Ratio:
0.88










Boots Star Rating:
N/A less than 5 Scans












Scan #
SPF
Critical Wavelength




1
26.52
382



2
21.13
375










In addition to the simple ester alkoxy crylene compounds of formula (I)-(V), the alkoxy crylene moieties can be attached as one or more terminal moieties on a polyester molecule, such as the alkoxy derivatives of the Di (NPG Crylene) Fumerate polyesters disclosed in this assignee's U.S. Pat. No. 7,235,587 ('587), hereby incorporated by references, as shown in formula (VI):




embedded image



wherein A and B are the same or different and are selected from the group consisting of oxygen, amino and sulfur; R1 and R3 are the same or different and are selected from the group consisting of C1-C30 alkyl, C2-C30 alkylene, C2-C30 alkyne, C3-C8 cycloalkyl, C1-C30 substituted alkylene, C2-C30 substituted alkyne, aryl, substituted aryl, heteroaryl, heterocycloalkyl, substituted heteroaryl and substituted heterocycloalkyl; R2 is selected from the group consisting of C1-C30 alkyl, C2-C30 alkylene, C2-C30 alkyne, C3-C8 cycloalkyl, C1-C30 substituted alkyl, C3-C8 substituted cycloalkyl, C1-C30 substituted alkylene, C2-C30 substituted alkyne; R4, R5, R6 and R7 are the same or different and are selected from the group consisting of C1-C30 alkoxy straight chain on branched, and a, b, c and d are each either 0 or 1, and a, b, c and d add up to 1, 2, 3, or 4.

Claims
  • 1. A photostabilized photoactive sunscreen composition comprising a mixture of a photon-excited photoactive compound that reaches a singlet excited state when exposed to UV radiation and a compound of formula (I) in an amount sufficient to accept the singlet excited state energy from said photoactive compound to quench the singlet excited state energy from the photon-excited photoactive compound and transfer the singlet excited state energy from the photon-excited photoactive compound to the compound of formula (I) thereby returning the photon-excited photoactive compound to its ground state so that the photon-excited photoactive compound can absorb more photons from UV radiation before it undergoes a photochemical reaction destructive to its UV-absorbing capability, thereby photostabilizing said photoactive compound:
  • 2. The photostabilized photoactive composition of claim 1, wherein R1 is methoxy and R2 is hydrogen.
  • 3. The photostabilized photoactive composition of claim 2, wherein R3 is a C12-C30 straight chain or branched alkyl.
  • 4. The photostabilized photoactive composition of claim 1, wherein R2 is methoxy and R1 is hydrogen.
  • 5. The photostabilized photoactive composition of claim 1, wherein the compound of formula (I) is present in an amount in the weight range of 0.1% to 20%, based on the total weight of the composition.
  • 6. The photostabilized photoactive composition of claim 1, wherein the compound of formula (I) is present in an amount in this weight range of 0.5% to 10%, based on the total weight of the composition.
  • 7. The photostabilized photoactive composition of claim 1, wherein the compound of formula (I) is present in an amount in this weight range of 0.1% to 10%, based on the total weight of the composition.
  • 8. The photostabilized photoactive composition of claim 7, wherein the compound of formula (I) is present in an amount in this weight range of 3% to 8%, based on the total weight of the composition.
  • 9. The photostabilized photoactive composition of claim 1, wherein the photoactive compound is selected from the group consisting of p-aminobenzoic acid and salts and derivatives thereof; anthranilate and derivatives thereof; dibenzoylmethane and derivatives thereof; salicylate and derivatives thereof; cinnamic acid and derivatives thereof; dihydroxycinnamic acid and derivatives thereof; camphor and salts and derivatives thereof; trihydroxycinnamic acid and derivatives thereof; dibenzalacetone naptholsulfonate and salts and derivatives thereof; benzalacetophenone naphtholsulfonate and salts and derivatives thereof; dihydroxy-naphthoic acid and salts thereof; o-hydroxydiphenyldisulfonate and salts and derivatives thereof; p-hydroxdydiphenyldisulfonate and salts and derivatives thereof; coumarin and derivatives thereof; diazole derivatives; quinine derivatives and salts thereof; quinoline derivatives; hydroxyl-substituted benzophenone derivatives; naphthalate derivatives; methoxy-substituted benzophenone derivatives; uric acid derivatives; vilouric acid derivatives; tannic acid and derivatives thereof; hydroquinone; benzophenone derivatives; 1,3,5-triazine derivatives; phenyldibenzimidazole tetrasulfonate and salts and derivatives thereof; terephthalyidene dicamphor sulfonic acid and salts and derivatives thereof; methylene bis-benzotriazolyl tetramethylbutylphenol and salts and derivatives thereof; bis-ethylhexyloxyphenol methoxyphenyl triazine and salts, diethylamino hydroxyl benzoyl and derivatives thereof; and combinations of the foregoing.
  • 10. The photostabilized photoactive composition of claim 9, wherein the photoactive compound comprises a derivative of cinnamic acid.
  • 11. The photostabilized photoactive composition of claim 10, wherein the photoactive compound comprises 2-ethylhexyl-p-methoxycinnamate.
  • 12. The photostabilized photoactive composition of claim 10, wherein the photoactive compound comprises isoamyl methoxycinnamate.
  • 13. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises a dibenzoylmethane derivative.
  • 14. The photostabilized photoactive composition of claim 13, further including a cinnamate ester.
  • 15. The photostabilized photoactive composition of claim 14, wherein the cinnamate ester is selected from the group consisting of 2-ethylhexyl p-methoxycinnamate, isoamyl p-methoxycinnamate, and a combination thereof.
  • 16. The photostabilized photoactive composition of claim 15 wherein the cinnamate ester is 2-ethylhexyl p-methoxycinnamate.
  • 17. The photostabilized photoactive composition of claim 16, further including bis-ethylhexyloxyphenol methoxyphenyl triazine in an amount of 0.1 to 10 wt. %.
  • 18. The photostabilized photoactive composition of claim 16, further including diethylhexyl syringylidene malonate in an amount of 0.1 to 10 wt. %.
  • 19. The photostabilized photoactive composition of claim 16, further including methylene bis-benzotriazoyl tetramethylbutyl phenol in an amount of 0.1 to 10 wt. %.
  • 20. The photostabilized photoactive composition of claim 16, further including diethylamino hydroxybenzoyl hexylbenzoate in an amount of 0.1 to 10 wt. %.
  • 21. The photostabilized photoactive composition of claim 16, further including disodium phenyldibenzylimidazole sulfonic acid in an amount of 0.1 to 10 wt. %.
  • 22. The photostabilized photoactive composition of claim 16, further including 4-methylbenzilidene camphor.
  • 23. The photostabilized photoactive composition of claim 16, further including phenylbenzimidazole sulfonic acid or salt thereof in an amount of 0.1 to 10 wt. %.
  • 24. The photostabilized photoactive composition of claim 13, wherein the dibenzoylmethane derivative comprises butylmethoxy dibenzoylmethane.
  • 25. The photostabilized photoactive composition of claim 24, further including a salicylate or a derivative thereof in an amount of 0.1 to 10 wt %.
  • 26. The photostabilized photoactive composition of claim 13, wherein the photoactive compound comprises a dibenzoylmethane derivative selected from the group consisting of 2-methyldibenzoylmethane; 4-methyldibenzoylmethane; 4-isopropyldibenzoylmethane; 4-tert-butyldibenzoylmethane; 2,4-dimethydibenzoylmethane; 2-5-dimethydibenzoylmethane; 4,4-diispropyldibenzoylmethane; 4,4-dimethoxydibenzoylmethane; 4-tert-butyl-4-methoxdibenzoylmethane; 2-methyl-5-isopropy-4-methoxydibenzoylmethane; 2-methyl-5-tert-butyl-4-methoxydibenzoylmethane; 2,4-dimethyl-4-methoxydibenzoymethane; 2,6-dimethyl-4-tert-butyl-4-methoxydibenxoylmethane, and combinations thereof.
  • 27. The photostabilized photoactive composition of claim 26 further including 0.1 to 10 wt. % of a triplet quencher selected from the group consisting of octocrylene, methyl benzylidene camphor, diethylhexyl 2,6-naphthalate, diethylhexyl syringylidene malonate, and combinations thereof.
  • 28. The photostabilized photoactive composition of claim 1, further including a naphthalene dicarboxylic acid ester in an amount of 0.1 to 10 wt %.
  • 29. The photostabilized photoactive composition of claim 28, wherein the naphthalene dicarboxylic acid ester comprises a diethylhexyl 2,6-naphthalene dicarboxylic acid ester.
  • 30. The photostabilized photoactive composition of claim 28 further comprising 0.1 to 10 wt. % benzophenone-3.
  • 31. The photostabilized photoactive composition of claim 28 further comprising 0.1 to 10 wt. % octyl salicylate.
  • 32. The photostabilized photoactive composition of claim 1, further including a salicylate or a derivative thereof in an amount of 0.1 to 10 wt %.
  • 33. The photostabilized photoactive composition of claim 1, further including a benzophenone or a derivative thereof in an amount of 0.1 to 10 wt. %.
  • 34. The photostabilized photoactive composition of claim 33, wherein the benzophenone comprises benzophenone-3 in an amount of 0.1 to 10 wt. %.
  • 35. The photostabilized photoactive composition of claim 33, wherein the photoactive compound is selected from the group consisting of a dibenzoylmethane derivative; Octocrylene; a naphthalene dicarboxylic acid ester; diethylhexyl syringylidene malonate; 4-methylbenzilidene-camphor 4-methylbenzilidene camphor; and combinations thereof.
  • 36. The photostabilized photoactive composition of claim 1, wherein the photoactive compound comprises a 1,3,5-triazine derivative.
  • 37. The photostabilized photoactive composition of claim 1, that includes an ester of cyanodiphenyl propenoic acid.
  • 38. The photostabilized photoactive composition of claim 1, wherein the mixture includes methyl benzylidene camphor.
  • 39. The photostabilized photoactive composition of claim 1, wherein the composition includes a compound selected from the group consisting of methylene bis-benzotriazolyl tetramethylbutylphenol, salts and derivatives thereof; bis-ethylhexyloxyphenol methoxyphenyl triazine, and salts and derivatives thereof.
  • 40. The photostabilized photoactive composition of claim 1, wherein the composition includes a hydroxyl-substituted benzophenone derivative or a methoxy-substituted benzophenone derivative, or a combination thereof.
  • 41. The photostabilized photoactive composition of claim 1, further comprising a diester or polyester of naphthalene dicarboxylic acid selected from the group consisting of compounds of formula (II) and (III), and combinations thereof:
  • 42. The photostabilized photoactive composition of claim 1, comprising a diester of formula (III) wherein R1 and R2 are 2-ethylhexyl.
  • 43. The photostabilized photoactive composition of claim 1, wherein said mixture includes a cosmetically acceptable carrier.
  • 44. The photostabilized photoactive composition of claim 1, wherein said mixture includes an oil phase having a dielectric constant of at least about 8.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. application Ser. No. 11/891,281, filed Aug. 9, 2007 now U.S. Pat. No. 7,597,825. The entire text of the priority application is incorporated herein by reference in its entirety.

US Referenced Citations (49)
Number Name Date Kind
2623060 Cragoe Dec 1952 A
3215724 Strobel et al. Nov 1965 A
3337357 Strobel et al. Aug 1967 A
4284621 Preuss et al. Aug 1981 A
4293542 Lang et al. Oct 1981 A
4307240 Ching Dec 1981 A
4396240 Henson Aug 1983 A
4562278 Hill Dec 1985 A
4617374 Pruett et al. Oct 1986 A
4707537 Pruett et al. Nov 1987 A
5576354 Deflandre et al. Nov 1996 A
5663213 Jones et al. Sep 1997 A
5738842 Raspanti et al. Apr 1998 A
5783307 Fagerburg et al. Jul 1998 A
5989528 Tanner et al. Nov 1999 A
5993789 Bonda et al. Nov 1999 A
6001952 Carman et al. Dec 1999 A
6113931 Bonda et al. Sep 2000 A
6225052 Batz et al. May 2001 B1
6284916 Bonda et al. Sep 2001 B1
6485713 Bonda et al. Nov 2002 B1
6518451 Bonda et al. Feb 2003 B2
6537529 Bonda Mar 2003 B1
6551605 Bonda Apr 2003 B2
6800274 Bonda et al. Oct 2004 B2
6890521 Bonda May 2005 B2
6899866 Bonda May 2005 B2
6905525 Wood et al. Jun 2005 B2
6919473 Bonda et al. Jul 2005 B2
6962692 Bonda et al. Nov 2005 B2
7064114 Yiv et al. Jun 2006 B2
7201893 Wendel et al. Apr 2007 B2
7235587 Bonda et al. Jun 2007 B2
7292156 Smith et al. Nov 2007 B2
7449698 Nguyen et al. Nov 2008 B2
7534420 Bonda et al. May 2009 B2
20020127192 Murphy et al. Sep 2002 A1
20030000130 Wood et al. Jan 2003 A1
20030176542 Abe et al. Sep 2003 A1
20040047817 Bonda Mar 2004 A1
20040047818 Bonda Mar 2004 A1
20040170579 Mobius Sep 2004 A1
20040247539 Wendel et al. Dec 2004 A1
20050191249 Bonda et al. Sep 2005 A1
20060002869 Bonda et al. Jan 2006 A1
20060228311 Bonda et al. Oct 2006 A1
20080286217 Chaudhuri Nov 2008 A1
20090041847 Bonda et al. Feb 2009 A1
20090246157 Bonda et al. Oct 2009 A1
Foreign Referenced Citations (11)
Number Date Country
1222926 Aug 1966 DE
570838 Nov 1993 EP
0 711 803 May 1996 EP
0761201 Mar 1997 EP
1323743 Jul 2003 EP
08225672 Sep 1996 JP
2005139263 Jun 2005 JP
1273360 Nov 1986 SU
WO-0027337 May 2000 WO
WO-0242368 May 2002 WO
WO-2007128840 Nov 2007 WO
Related Publications (1)
Number Date Country
20090074687 A1 Mar 2009 US
Divisions (1)
Number Date Country
Parent 11891281 Aug 2007 US
Child 12260278 US